There are 22 papers on aging in Severe acute: 7 observational studies in people, 2 in cells, 12 reviews.
22 papers study it2 findings
See all 22 papers on Severe acute
- Humans7
- Cells2
- In silico1
Interventions
1Nicotinamide riboside
mixedhumanACE21downSARS-CoV-2RdRp1
1 study
Nicotinamide riboside
mixedhumanACE21downSARS-CoV-2RdRp1
Nicotinamide riboside is associated with humanACE2 in silico (molecular docking and dynamics simulation).
“Nicotinamide Riboside and its active metabolite NMN can target human ACE2 and IMPDH”
In silicomolecular docking and dynamics simulation
Journal of molecular structure
Nicotinamide riboside inhibits SARS-CoV-2RdRp in silico (molecular docking and dynamics simulation).
“RdRp as a potential competitive inhibitor”
In silicomolecular docking and dynamics simulation
Journal of molecular structure
Latest
2 papers in 12 monthsFrontiers in Immunology
Continuous antiretroviral therapy induces progressive senescence-like reprogramming of alveolar macrophages
Cohort study in peopleEpigenetic regulation of gene expression
Frontiers in Immunology
Cellular sensor DAP5 decodes Betacoronaviral NSP5 to drive virus-induced senescence
Experiments in human cellsCellular senescence
Vaccines
Immune Responses to SARS-CoV-2 Variants WT and XBB.1.9: Assessing Vulnerabilities and Preparedness
Cross-sectional study in peopleBlood and immune system
medRxiv
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology
Preprint: cohort study of 1,031 peopleMechanisms
Annals of Translational Medicine
Immunosenescence is a therapeutic target for frailty in older adults: a narrative review
ReviewMechanisms
Immunity & Ageing
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
ReviewInflammation